Literature DB >> 34392449

Increased unfolded protein responses caused by MED17 mutations.

Takeshi Terabayashi1, Satoru Hashimoto2,3.   

Abstract

Mediator (MED) is a key regulator of protein-coding gene expression, and mutations in MED subunits are associated with a broad spectrum of diseases. Because mutations in MED17 result in autosomal recessive disorders, including microcephaly, intellectual disability, epilepsy, and ataxia, which are barely reported, with only three case reports to date, genotype-phenotype association should be elucidated. Here, we investigated the impact of MED17 mutations on cellular responses and found increased unfolded protein responses (UPRs) in fibroblasts derived from Japanese patients with MED17 mutations. The expression of the UPR genes CHOP and ATF4 was upregulated, and the phosphorylation of eIF2a was basally increased in patients' cells. Based on our findings, we propose that increased UPRs caused by MED17 mutations might contribute to the clinical phenotype.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Choreiform movement; MED17; Mediator complex; Unfold protein responses

Mesh:

Substances:

Year:  2021        PMID: 34392449     DOI: 10.1007/s10048-021-00661-6

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  20 in total

1.  MED23 mutation links intellectual disability to dysregulation of immediate early gene expression.

Authors:  Satoru Hashimoto; Sarah Boissel; Mohammed Zarhrate; Marlène Rio; Arnold Munnich; Jean-Marc Egly; Laurence Colleaux
Journal:  Science       Date:  2011-08-26       Impact factor: 47.728

2.  Human mediator subunit MED26 functions as a docking site for transcription elongation factors.

Authors:  Hidehisa Takahashi; Tari J Parmely; Shigeo Sato; Chieri Tomomori-Sato; Charles A S Banks; Stephanie E Kong; Henrietta Szutorisz; Selene K Swanson; Skylar Martin-Brown; Michael P Washburn; Laurence Florens; Chris W Seidel; Chengqi Lin; Edwin R Smith; Ali Shilatifard; Ronald C Conaway; Joan W Conaway
Journal:  Cell       Date:  2011-07-08       Impact factor: 41.582

3.  MED12-related XLID disorders are dose-dependent of immediate early genes (IEGs) expression.

Authors:  Lise-Marie Donnio; Baptiste Bidon; Satoru Hashimoto; Melanie May; Alexey Epanchintsev; Colm Ryan; William Allen; Anna Hackett; Jozef Gecz; Cindy Skinner; Roger E Stevenson; Arjan P M de Brouwer; Charles Coutton; Christine Francannet; Pierre-Simon Jouk; Charles E Schwartz; Jean-Marc Egly
Journal:  Hum Mol Genet       Date:  2017-06-01       Impact factor: 6.150

4.  Novel role for mediator complex subunit Srb5/Med18 in termination of transcription.

Authors:  Banupriya Mukundan; Athar Ansari
Journal:  J Biol Chem       Date:  2011-09-14       Impact factor: 5.157

5.  MED20 mutation associated with infantile basal ganglia degeneration and brain atrophy.

Authors:  Julia Vodopiutz; Maria T Schmook; Vassiliki Konstantopoulou; Barbara Plecko; Susanne Greber-Platzer; Marc Creus; Rainer Seidl; Andreas R Janecke
Journal:  Eur J Pediatr       Date:  2014-12-03       Impact factor: 3.183

Review 6.  Function and regulation of the Mediator complex.

Authors:  Ronald C Conaway; Joan Weliky Conaway
Journal:  Curr Opin Genet Dev       Date:  2011-02-15       Impact factor: 5.578

7.  Mediator MED23 regulates basal transcription in vivo via an interaction with P-TEFb.

Authors:  Wei Wang; Xiao Yao; Yan Huang; Xiangming Hu; Runzhong Liu; Dongming Hou; Ruichuan Chen; Gang Wang
Journal:  Transcription       Date:  2013 Jan-Feb

Review 8.  The Mediator complex: a central integrator of transcription.

Authors:  Benjamin L Allen; Dylan J Taatjes
Journal:  Nat Rev Mol Cell Biol       Date:  2015-02-18       Impact factor: 94.444

9.  De Novo Missense Substitutions in the Gene Encoding CDK8, a Regulator of the Mediator Complex, Cause a Syndromic Developmental Disorder.

Authors:  Eduardo Calpena; Alexia Hervieu; Teresa Kaserer; Sigrid M A Swagemakers; Jacqueline A C Goos; Olajumoke Popoola; Maria Jesus Ortiz-Ruiz; Tina Barbaro-Dieber; Lucy Bownass; Eva H Brilstra; Elise Brimble; Nicola Foulds; Theresa A Grebe; Aster V E Harder; Melissa M Lees; Kristin G Monaghan; Ruth A Newbury-Ecob; Kai-Ren Ong; Deborah Osio; Francis Jeshira Reynoso Santos; Maura R Z Ruzhnikov; Aida Telegrafi; Ellen van Binsbergen; Marieke F van Dooren; Peter J van der Spek; Julian Blagg; Stephen R F Twigg; Irene M J Mathijssen; Paul A Clarke; Andrew O M Wilkie
Journal:  Am J Hum Genet       Date:  2019-03-21       Impact factor: 11.025

10.  Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal models.

Authors:  Alejandro Leal; Kathrin Huehne; Finn Bauer; Heinrich Sticht; Philipp Berger; Ueli Suter; Bernal Morera; Gerardo Del Valle; James R Lupski; Arif Ekici; Francesca Pasutto; Sabine Endele; Ramiro Barrantes; Corinna Berghoff; Martin Berghoff; Bernhard Neundörfer; Dieter Heuss; Thomas Dorn; Peter Young; Lisa Santolin; Thomas Uhlmann; Michael Meisterernst; Michael Werner Sereda; Ruth Martha Stassart; Gerd Meyer Zu Horste; Klaus-Armin Nave; André Reis; Bernd Rautenstrauss
Journal:  Neurogenetics       Date:  2009-10       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.